GSK PLC (GSK)
41.12
+0.22
(+0.53%)
USD |
NYSE |
Apr 26, 16:00
41.12
0.00 (0.00%)
After-Hours: 18:02
GSK Total Return Level: 268.23 for April 25, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 25, 2024 | 268.23 |
April 24, 2024 | 267.90 |
April 23, 2024 | 270.39 |
April 22, 2024 | 266.13 |
April 19, 2024 | 260.62 |
April 18, 2024 | 257.48 |
April 17, 2024 | 259.64 |
April 16, 2024 | 261.93 |
April 15, 2024 | 265.54 |
April 12, 2024 | 266.59 |
April 11, 2024 | 267.51 |
April 10, 2024 | 266.79 |
April 09, 2024 | 268.03 |
April 08, 2024 | 267.84 |
April 05, 2024 | 270.06 |
April 04, 2024 | 267.90 |
April 03, 2024 | 272.36 |
April 02, 2024 | 274.00 |
April 01, 2024 | 278.13 |
March 28, 2024 | 281.08 |
March 27, 2024 | 281.87 |
March 26, 2024 | 280.55 |
March 25, 2024 | 280.82 |
March 22, 2024 | 277.67 |
March 21, 2024 | 277.80 |
Date | Value |
---|---|
March 20, 2024 | 274.92 |
March 19, 2024 | 277.47 |
March 18, 2024 | 276.29 |
March 15, 2024 | 276.62 |
March 14, 2024 | 282.46 |
March 13, 2024 | 284.29 |
March 12, 2024 | 283.70 |
March 11, 2024 | 281.41 |
March 08, 2024 | 282.85 |
March 07, 2024 | 285.73 |
March 06, 2024 | 279.44 |
March 05, 2024 | 279.31 |
March 04, 2024 | 278.26 |
March 01, 2024 | 275.57 |
February 29, 2024 | 274.72 |
February 28, 2024 | 277.60 |
February 27, 2024 | 277.87 |
February 26, 2024 | 277.60 |
February 23, 2024 | 276.82 |
February 22, 2024 | 276.42 |
February 21, 2024 | 272.36 |
February 20, 2024 | 272.88 |
February 16, 2024 | 272.36 |
February 15, 2024 | 271.25 |
February 14, 2024 | 271.45 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
173.07
Minimum
Mar 23 2020
354.99
Maximum
Apr 13 2022
238.10
Average
227.22
Median
Jul 20 2023
Total Return Level Benchmarks
AstraZeneca PLC | 214.84 |
Haleon PLC | 8.618 |
Novo Nordisk A/S | 218.87 |
Pfizer Inc | 86.33 |
Sanofi SA | 105.37 |